PT - JOURNAL ARTICLE AU - Green, Dylan AU - Coomes, David AU - Barnabas, Ruanne V. AU - Sharma, Monisha AU - Barr-Dichiara, Magdalena AU - Jamil, Muhammad S. AU - Owiredu, Morkor Newman AU - Macdonald, Virginia AU - Nguyen, Van AU - Hai, Son Vo AU - Wi, Theodora E. AU - Johnson, Cheryl AU - Drake, Alison L. TI - Impact and cost-effectiveness of frequent HIV re-testing among key populations in Viet Nam: a modeling study AID - 10.1101/2022.03.01.22271733 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.01.22271733 4099 - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271733.short 4100 - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271733.full AB - Background HIV testing and counseling is a key component of HIV prevention and the entry point into the treatment cascade, which improves for individual clinical outcomes and reduces onward HIV transmission. Current guidelines recommend at least annual testing for key populations. More frequent testing could provide health benefits, but these additional services increase the program the cost-effectiveness is not well-evaluated.Methods We used a compartmental mathematical model to simulate the health and economic impact of HIV testing one to four times per year for men who have sex with men, people who inject drugs, and female sex workers in Viet Nam. Model outcomes included costs, HIV infections, HIV-related deaths, and disability-adjusted life years (DALYs) associated with each scenario. We used an opportunity cost-based cost-effectiveness threshold of US $2,255 per DALY averted, discounted costs and health benefits at 3% annually, and used a time horizon from 2021 to 2030 to calculate incremental cost-effectiveness ratios (ICERs).Results Compared to the baseline scenario, more frequent HIV testing was estimated to incrementally avert 10.2%, 5.2%, 3.0%, and 1.6% discounted infections for one-, two-, three-, and four-tests per year, respectively. ICERs associated with each scenario ranged from $464, $1,190, $1,762, and $2,727 per DALY averted for one-, two-, three-, and four-tests per year, respectively.Conclusions Increased HIV testing frequency for key populations was projected to avert HIV incidence, mortality, and disability in Viet Nam and was cost-effective. Settings with a similar context should consider strategies on how to optimize retesting among key populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the World Health OrganizationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors